ANDREW CIVITELLO to Treatment Outcome
This is a "connection" page, showing publications ANDREW CIVITELLO has written about Treatment Outcome.
Connection Strength
0.429
-
Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices. J Artif Organs. 2023 Dec; 26(4):275-286.
Score: 0.069
-
Medium to long-term ventricular assist device support in adults with congenital heart disease. J Heart Lung Transplant. 2025 Feb; 44(2):278-281.
Score: 0.020
-
Continuous-Flow Ventricular Assist Device Support in Adult Congenital Heart Disease: A 15-Year, Multicenter Experience of Temporary and Durable Support. ASAIO J. 2023 05 01; 69(5):429-437.
Score: 0.017
-
Distinctive kidney function trajectories following left ventricular assist device implantation. J Heart Lung Transplant. 2022 12; 41(12):1798-1807.
Score: 0.017
-
Key Concepts Surrounding Cardiogenic Shock. Curr Probl Cardiol. 2022 Nov; 47(11):101303.
Score: 0.017
-
Preoperative hyponatremia and survival after left ventricular assist device implantation. Artif Organs. 2022 Sep; 46(9):1923-1931.
Score: 0.017
-
The influence of preoperative dialysis on survival after continuous-flow left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2022 02 21; 34(3):470-477.
Score: 0.016
-
Continuous-Flow Left Ventricular Assist Device Support in Patients with Ischemic Versus Nonischemic Cardiomyopathy. Tex Heart Inst J. 2021 Sep 01; 48(4).
Score: 0.016
-
Continuous-Flow Left Ventricular Assist Device Explantation After More Than 5 Years of Circulatory Support and Ventricular Reconditioning. Tex Heart Inst J. 2021 06 10; 48(2).
Score: 0.016
-
Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients. J Artif Organs. 2022 Mar; 25(1):16-23.
Score: 0.016
-
Effect of cardiac arrest with aortic cross-clamping during left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2020 01 01; 30(1):47-53.
Score: 0.014
-
Concomitant valve procedures in patients undergoing continuous-flow left ventricular assist device implantation: A single-center experience. J Thorac Cardiovasc Surg. 2019 10; 158(4):1083-1089.e1.
Score: 0.013
-
Fatal Neurologic Dysfunction During Continuous-Flow Left Ventricular Assist Device Support. Ann Thorac Surg. 2019 04; 107(4):1132-1138.
Score: 0.013
-
Effect of Preoperative Atrial Fibrillation on Patients with Chronic Heart Failure Who Undergo Long-Term Continuous-Flow LVAD Implantation. ASAIO J. 2018 Sep-Oct; 64(5):594-600.
Score: 0.013
-
Left Ventricular Recovery with Explantation of Continuous-Flow Left Ventricular Assist Device after 5 Years of Support. Ann Thorac Cardiovasc Surg. 2021 Jun 20; 27(3):211-214.
Score: 0.013
-
Continuous-Flow Left Ventricular Assist Device Therapy in Adults with Transposition of the Great Vessels. Ann Thorac Cardiovasc Surg. 2021 Feb 20; 27(1):64-67.
Score: 0.013
-
Predictive value of preoperative serum albumin levels on outcomes in patients undergoing LVAD implantation. J Card Surg. 2018 Aug; 33(8):469-478.
Score: 0.013
-
Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2018 08; 106(2):513-519.
Score: 0.013
-
Bridging to a Long-Term Ventricular Assist Device With Short-Term Mechanical Circulatory Support. Artif Organs. 2018 Jun; 42(6):589-596.
Score: 0.013
-
Effect of obesity on outcomes in patients undergoing implantation of continuous-flow left ventricular assist devices. J Artif Organs. 2018 Jun; 21(2):180-187.
Score: 0.012
-
Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle. Ann Thorac Surg. 2018 03; 105(3):799-806.
Score: 0.012
-
Outcomes in patients with advanced heart failure and small body size undergoing continuous-flow left ventricular assist device implantation. J Artif Organs. 2018 Mar; 21(1):31-38.
Score: 0.012
-
Perforation of a HeartMate II outflow graft. J Card Surg. 2017 Mar; 32(3):233-234.
Score: 0.012
-
Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol. 2017 Jan; 48(1):27-34.
Score: 0.011
-
Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure. J Thorac Cardiovasc Surg. 2015 Jan; 149(1):267-75, 278.e1.
Score: 0.010
-
The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol. 2014 Feb; 27(1):1-11.
Score: 0.009
-
Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant. 2008 Jan; 27(1):106-11.
Score: 0.006
-
Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol. 2006 Mar; 18(3):93-6.
Score: 0.005